Bo Ahrén chercheur
Ahrén, Bo
VIAF ID: 315221734 (Personal)
Permalink: http://viaf.org/viaf/315221734
Preferred Forms
-
-
-
- 100 1 _ ‡a Ahrén, Bo
- 100 0 _ ‡a Bo Ahrén ‡c chercheur
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
Analogi GLP-1 i inhibitory DPP-IV w leczeniu cukrzycy typu 2 | |
European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004 | |
Evidence for contribution by increased cytoplasmic Na+ to the insulinotropic action of PACAP38 in HIT-T15 cells | |
Evidence for neural contribution to islet effects of DPP-4 inhibition in mice | |
Evidence for time dependent variation of glucagon secretion in mice | |
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver | |
Extraction of epinephrine and norepinephrine by the dog pancreas in vivo | |
Factors influencing the release of cyclic AMP from mouse thyroid tissue stimulated by TSH in vitro | |
Failure of somatostatin to eliminate the glucagon release induced by baroreceptor unloading in the cat | |
Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women. | |
Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial | |
Fat feeding impairs glycogen synthase activity in mice without effects on its gene expression | |
Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice | |
Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes. | |
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy | |
Galanin: a novel pancreatic neuropeptide | |
Galanin exerts dual action on inositol-specific phospholipase C activity in isolated pancreatic islets | |
Galanin-immunoreactive nerves in the mouse and rat pancreas | |
Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice | |
Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction | |
Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high fat diet mice | |
Involvement of nitric oxide in neuroglycopenia-induced insulin and glucagon secretion in the mouse | |
Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets | |
Ischaemic and metabolic treatment of hepatic tumours | |
[Ischemic treatment of cancer--a break-through?] | |
Islet adaptation to insulin resistance: mechanisms and implications for intervention | |
Islet amyloid and type 2 diabetes mellitus | |
Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes | |
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. | |
Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice | |
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes | |
Islet phospholipase A(2) activation is potentiated in insulin resistant mice | |
Islet transplantation to the renal subcapsular space in streptozotocin-diabetic rats. Long-term effects on insulin and glucagon secretion | |
Kinetics of radioiodine released from prelabelled thyroid gland in vivo: influence of propylthiouracil | |
Large differences in serum leptin levels between nonwesternized and westernized populations: the Kitava study | |
Leptin--a regulator of islet function?: its plasma levels correlate with glucagon and insulin secretion in healthy women. | |
Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics | |
Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. | |
Leptin is associated with increased risk of myocardial infarction. | |
Leptin is closely related to body fat in prepubertal children aged 8-11 years | |
Leptin is reduced in lean subjects with type 2 diabetes in bangladesh | |
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial) | |
Liver cirrhosis in rats: regeneration and assessment of the role of phenobarbital | |
Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. | |
Liver regeneration following 68% partial orthotopic liver transplantation in the rat | |
Local Growth Factors Are Beneficial for the Autonomic Reinnervation of Transplanted Islets in Rats | |
Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas | |
Long-term effects of alloxan in mice | |
Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice | |
Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice | |
Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males | |
Low CSF leptin in female suicide attempters with major depression. | |
Low serum insulin in traditional Pacific Islanders--the Kitava Study | |
Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. | |
Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice | |
Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans | |
Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets | |
Methods and models for metabolic assessment in mice | |
Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice | |
Mitomycin C and lipiodol do not improve the effect of intermittent hepatic artery occlusion on liver tumour growth. An experimental study in the rat | |
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes | |
Modulation of basal insulin secretion in the obese, hyperglycemic mouse | |
Modulatory role of adrenergic nerves on dexamethasone-induced islet cell NPY expression in the rat: evidence from chemical sympathectomy | |
Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography | |
N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets | |
Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion | |
Neuropeptide Y is expressed in subpopulations of insulin- and non-insulin-producing islet cells in the rat after dexamethasone treatment: a combined immunocytochemical and in situ hybridisation study. | |
Neuropeptides in the regulation of islet hormone secretion--localization, effects and mode of action | |
Neuropeptides in the Thyroid Gland: Distribution of Substance P and Gastrin/Cholecystokinin and Their Effects on the Secretion of Iodothyronine and Calcitonin* | |
[New strategy in type 2 diabetes tested in clinical trials. Glucagon-like peptide 1 | |
On the peptidergic and aminergic regulation of insulin secretion / Bo Ahrén |